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Abstract The development of synthetic methodologies
for cyclic peptides is driven by the discovery of cyclic
peptide drug scaffolds such as the plant-derived cyclotides,
sunflower trypsin inhibitor 1 (SFTI-1) and the development
of cyclized conotoxins. Currently, the native chemical
ligation reaction between an N-terminal cysteine and
C-terminal thioester group remains the most robust method
to obtain a head-to-tail cyclized peptide. Peptidyl thioesters
are effectively generated by Boc SPPS. However, their
generation is challenging using Fmoc SPPS because thio-
ester linkers are not stable to repeated piperidine exposure
during deprotection. Herein we describe a Fmoc-based
protocol for synthesizing cyclic peptides adapted for
microwave assisted solid phase peptide synthesis. The
protocol relies on the linker Di-Fmoc-3,4-diaminobenzoic
acid, and we demonstrate the use of Gly, Ser, Arg and Ile
as C-terminal amino acids (using HBTU and HATU as
coupling reagents). Following synthesis, an N-acylurea
moiety is generated at the C-terminal of the peptide; the
resin bound acylurea peptide is then deprotected and
cleaved from the resin. The fully deprotected peptide
undergoes thiolysis in aqueous buffer, generating the
thioester in situ. Ultimately, the head-to-tail cyclized peptide
is obtained via native chemical ligation. Two naturally
occurring cyclic peptides, the prototypical Mo¨bius cyclotide
kalata B1 and SFTI-1 were synthesized efficiently, avoiding
potential branching at the diamino linker, using the opti-
mized protocol. In addition, we demonstrate the possibility
to use the approach for the synthesis of long and synthetically
challenging linear sequences, by the ligation of two trun-
cated fragments of a 50-residue long plant defensin.
Keywords Fmoc SPPS  Microwave assisted peptide
synthesis  Native chemical ligation  Di-Fmoc-3,4-
diaminobenzoic acid  Cyclotide  kalata B1  SFTI-1
Introduction
The discovery of proteins whose ends are linked together to
produce a circular topology is an unique event in protein
biochemistry. Even though naturally occurring cyclic pep-
tide products, such as cyclosporine, have been known for
years, the presence of genetically encoded circular proteins
in nature became known only recently. Today it has been
established that organisms as diverse as bacteria, plants,
fungi and mammals contain the genomic blueprints that are
directly translated by nature’s ribosomal machinery into
circular proteins (Go¨ransson et al. 2012). Currently, the cy-
clotides (Craik et al. 1999) form the largest family of circular
proteins with more than 200 characterized members. These
proteins originate from plants and are commonly found
within the plant families Rubiaceae and Violaceae.
Cyclotides have captured significant interest because
they possess an ultra stable scaffold, the cyclic cystine
knot (CCK) motif, derived from the circular backbone and
three knotted disulfide bonds. In nature, cyclotides are
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presumably produced by plants to protect themselves
against insects (Jennings et al. 2001), although other bio-
activities, including anti-tumor (Lindholm et al. 2002;
Svanga˚rd et al. 2004), anti-bacterial (Gran et al. 2008;
Pra¨nting et al. 2010), uterotonic (Gran et al. 2008) and anti-
HIV (Gustafson et al. 2004), have been reported. A number
of 50,000 different cyclotide variants are predicted to be
present within the plant family Rubiaceae alone; thus
cyclotides represent a natural combinatorial template hav-
ing their inter-cysteine regions occupied by hypervariable
sequences (Wang et al. 2008). Cyclotides are currently a
target for bioengineering to take advantage of their plas-
ticity and exceptional stability: bioactive epitopes pertain-
ing to angiogenesis (Chan et al. 2011), anti-angiogenesis
(Gunasekera et al. 2008) and protease inhibitory activities
(Thongyoo et al. 2008; Thongyoo et al. 2009) have been
successfully grafted onto the cyclotide framework.
Another example of a ribosomally synthesized plant-
derived cyclic peptide is the 14-residue long sunflower
trypsin inhibitory 1 (SFTI-1) that was originally discovered
from the seeds of Helianthus annus (Luckett et al. 1999).
Within its compact structure, SFTI-1 combines a single
disulfide bond, a head-to-tail cyclized backbone and a
network of internal hydrogen bonds (Korsinczky et al.
2001). Native SFTI-1 has subnanomolar trypsin inhibitory
activity, and synthetic analogues of SFTI-1 have been
developed into inhibitors of proteases pivotal to the pro-
gression of breast and prostate cancers (Long et al. 2001;
Boy et al. 2010). Recently, proangiogenic epitopes were
successfully grafted onto SFTI-1 (Chan et al. 2011). Lack
of complete understanding of biosynthesis and peptide
cyclization mechanisms for cyclotides and SFTI-1 has
restricted their production by genetic approaches, and
currently chemical synthesis remains the most robust
approach to produce these molecules. With the rising
interest in cyclotides and SFTI-1 as peptide stabilizing
templates, it is becoming timely to explore novel approa-
ches for their syntheses. Furthermore, the capacity to
chemically synthesize these cyclic peptide templates also
provides opportunities to explore the structure–function
relationships of individual amino acids via synthetic
mutants. Methods of peptide backbone cyclization also
have general applicability, with several lines of evidence
indicating that cyclization is advantageous in terms of
augmenting the stability and bioavailability of therapeuti-
cally active peptides such as conotoxins (Clark et al. 2010;
Lovelace et al. 2011). The native chemical ligation (NCL)
reaction (Dawson et al. 1994) is one of the most popular
strategies to join two unprotected peptide segments to each
other through a native peptide bond, and can be used for
both the synthesis of circular proteins and peptides, and for
segmented synthesis of long and difficult peptide sequences
(Hackeng et al. 1999; Clark and Craik 2010; Aboye et al.
2011). The ligation requires an N-terminal Cys and a
C-terminal a-thioester, as outlined in Fig. 1a.
Unprotected C-terminal peptide thioesters, which are the
key starting material for NCL, can be directly assembled on
resin by Boc SPPS because the thioester is stable to the acidic
deprotection treatment used in Boc SPPS. However,
Boc SPPS has some drawbacks that make it unsuitable for
many laboratories: hazardous HF is used for the final cleavage
of the thioester peptide from the resin and the use of the strong
acid is incompatible with many posttranslational modifica-
tions (Mende and Seitz 2011). On the other hand, thioester
peptides are not directly accessible by Fmoc SPPS owing to
the nucleophilicity of the Fmoc-deprotecting agent piperidine,
although the Fmoc SPPS approach may be considered more
user friendly. Several methods have been developed to over-
come the problem of thioester instability in Fmoc SPPS; the
use of special linkers such as Kenner’s safety catch linkers,
using non-nucleophilic Fmoc deprotection cocktails or gen-
erating/activating the thioester group subsequent to the pep-
tide assembly (Kenner et al. 1971; Clippingdale et al. 2000;
Thongyoo et al. 2006; Park et al. 2010).
Recently, Dawson and coworkers described a method
for generation of peptide thioesters compatible with Fmoc
SPPS, based on a C-terminal N-acylurea peptide moiety
(Blanco-Canosa and Dawson 2008). As illustrated in
Fig. 1b, O-aminoanilides are used as stable synthetic
intermediates in that method, which in turn are transformed
to generate an N-acylbenzimidazolinone (N-acylurea)
functionality following peptide assembly. Acidic depro-
tection gives acylurea peptide, which in turn undergoes
thioesterification in neutral aqueous buffer. The C-terminal
thioester peptide can then participate in NCL in the pres-
ence of the counterpart N-terminal peptide containing the
Cys to join the N- and C-termini.
In the current work, we demonstrate the synthesis of
disulfide-rich cyclic peptides with accelerated speed of syn-
thesis and with high yields and purity using microwave
assisted Fmoc SPPS. In addition, we demonstrate the use of
the approach in a fragment-based synthesis of a larger
defensin. The doubly protected Di-Fmoc-3,4-diaminobenzoic
acid (illustrated in Fig. 1b) proves to be a useful linker, and
Gly, Ser, Arg and Ile were successfully used as starting points
for synthesis and subsequent conversion into thioesters.
Materials and Methods
Materials
All single Fmoc protected amino acids and Boc-Cys(Trt)-OH
were from Iris Biotech (Marktredwitz, Germany) or PepChem
(Tu¨bingen, Germany). Tentagel R Ram Rink-type resin
(0.18 mmol/g) and CLEAR amide resin (0.4 mmol/g) were
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from Peptide International (Louisville, KY). Fmoc-Pro
NovaSyn TGT (0.2 mmol/g) and Fmoc-Asp(OtBu)-
(Dmb)Gly–OH were from Novabiochem/Merck (Darmstadt,
Germany). Di-Fmoc-3,4-diaminobenzoic acid was pur-
chased from Anaspec (Fremont, CA). O-(7-Azabenzotriazol-
1-yl)-N,N,N0,N0-tetramethyluronium hexafluorophosphate
(HATU), O-(Benzotriazol-1-yl)-N,N,N0,N0-tetramethyluroni-
um hexafluorophosphate (HBTU) and Fmoc protected amino
acids were from PepChem. N,N-Dimethylformamide (DMF)
and dichloromethane (DCM) were from Thermo Fisher Sci-
entific (Waltham, MA). HPLC-grade acetonitrile (AcN) and
formic acid (FA) were from VWR (West Chester, PA).
Diethylether, diisopropylethylamine (DIPEA), guanidine
hydrochloride, reduced and oxidized glutathione, piperi-
dine, trifluoroacetic acid (TFA), triisopropylsilane (TIPS),
3,6-dioxa-1,8-octanedithiol (DODT), tris(2-carboxyethyl)
phosphine hydrochloride (TCEP), 4-mercaptophenylacetic
acid (MPAA) and 4-nitrophenyl chloroformate were from
Sigma-Aldrich (St Louis, MO). PD-10 Sephadex G-25M
columns were from GE Healthcare (Uppsala, Sweden).
HPLC and MS
RP-HPLC was performed on an A¨kta Basic (GE Health-
care) with detection at 215, 254 and 280 nm. Preparative
HPLC was done on a 250 9 10 (i.d.) mm Phenomenex
(Torrance, CA) C18 column (5 lm) at a flow rate of 4 ml/
min, and analytical HPLC were done on a 150 9 2 (i.d.)
mm Phenomenex C18 column (3 lm) at a flow rate of
0.3 ll/min. Solvents A (10 %AcN, 0.05 %TFA in water)
and B (60 %AcN, 0.05 %TFA in water) were used in a
linear gradient from of 0–70 % solvent B over 70 min for
the preparative HPLC. A linear gradient from 0 to 100 % B
over 30 min was used for analytical HPLC. MS and
Fig. 1 Schematic illustration of Native Chemical Ligation (NCL)
and N-acylurea based Fmoc SPPS synthesis of cyclic peptide
synthesis. a The thiolate group of the N-terminal cysteine residue
attacks the C-terminal thioester in the unprotected peptide in an
aqueous buffer at pH 7.0. This reversible transthioesterification step is
chemo- and region-selective and leads to the formation of a thioester
intermediate. That intermediate rearranges by an intramolecular S,N-
acyl shift to form the head-to-tail cyclized peptide. b In the current
work, Di-Fmoc-3,4-diaminobenzoic acid is used as a fully protected
linker for the first coupling to the rink amide resin. The linker is then
deprotected and peptide chain is elongated along one of the free
amino groups. Following coupling the N-terminal Boc-Cys, the free
amino group on the linker is acylated and thus activated, to yield the
resin bound N-acyl urea peptide. N-acylurea peptide is then fully
deprotected and cleaved from resin by strong cleavage. In situ
thioesterification and cyclization according to a then leads to peptide
ligation via an amide bond. A topologically circular molecule can be
obtained by NCL when the N-terminal cysteine and the C-terminal
thioester group are incorporated in the same peptide. Alternatively,
the truncated counterpart synthetic peptide fragments can be ligated
together to derive such long and difficult to synthesize peptides
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LC–MS were done on a LCQ classic (Finnigan/Thermo
Electron, San Jose, CA) and a Q-Tof Micro coupled online
with a nanoAcquity UPLC (Waters, Milford, MA), respec-
tively. LC–UV–MS was done using an Acquity TUV detector
(operated at 215 nm) coupled between the UPLC and the
Q-Tof Micro. LC–MS was done at a flow rate of 0.3 ll/min on
a Acquity UPLC BEH C18 column (1.7 lm, 150 9
0.075 mm) using solvents C (0.1 %FA in water) and D
(0.1 %FA in AcN). A linear gradient from 0 to 60 % solvent D in
solvent C over 40 min was used analysis. LC–UV–MS was done
using a Phenomenex C18 column (150 9 1 mm, 5 lm) eluted
at a flow rate of 40 ll/min and a linear gradient from 0 to 60 %
solvent D in solvent C over 40 min was used for the analysis.
Peptide Assembly
Kalata B1, SFTI-1Arg and SFT1-1Ile were synthesized on a
Tentagel R Ram Rink-type resin (0.19 mmol/g) on 0.1 mmol
scale. Defensin fragment 1 was synthesized on a CLEAR-
amide resin using 0.25 mmol scale. Defensin fragment 2 was
synthesized on 0.1 mmol scale using Fmoc-Pro-Novasyn
TGT preloaded resin. The conditions used in Table 1 were
used for the coupling of the Dbz linker and the amino acids to
the corresponding resins. Coupling of the Dbz and the first
C-terminal amino acid in kalata B1, SFTI-1Arg, SFTI-1Ile and
defensin peptide 1 were carried out manually. A microwave
assisted Fmoc/HBTU SPPS protocol on a Liberty1 micro-
wave peptide synthesizer (CEM Corp., Matthews, NC) was
then used for elongation of the full sequences. Defensin
fragment 2 was completely assembled in the automated
synthesizer. Fmoc-amino acids were Fmoc-Ala-OH, Fmoc-
Arg(Pbf)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Asp(OtBu)-OH,
Fmoc-Cys(Trt)-OH, Fmoc-Cys(Acm), Fmoc-Gln(Trt)-OH,
Fmoc-Glu(OtBu)-OH, Fmoc-Gly-OH, Fmoc-Ile-OH, Fmoc-
Leu-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-
Ser(tBu)-OH, Fmoc-Thr(tBu)-OH, Fmoc-Trp(Boc)-OH,
Fmoc-Tyr(tBu)-OH, Fmoc-Val-OH and the dipeptide Fmoc-
Asp(OtBu)-(Dmb)Gly-OH. To protect the N-terminus of the
peptide during subsequent acylation and to allow simulta-
neous deprotection, Boc-Cys(Trt)-OH was used in the final
coupling step for kalata B1 and SFTI. For defensin fragment
1, a Boc-Arg was coupled at the N-terminal. The following
conditions were used in the deprotection and coupling steps
in the automated peptide synthesizer (outlined in detail in
Table 1). Deprotection was repeated two times: 1 min
(38 W, 70 C) with 20 % piperidine in DMF (7 ml) followed
by of 20 % piperidine in DMF (7 ml) for 3 min (63 W,
70 C). The resin was washed with DMF (4 9 7 ml). Then
2.5 ml of the reagent mixture, containing amino acid
(5 equiv.) HBTU (5 equiv.) and DIPEA (10 equiv.) were
transferred to the reaction vessel. All amino acids were
coupled for 5 min (32 W, 70 C), except Cys and Arg. Cys
was coupled for a total time of 6 min (2 min at room tem-
perature, RT, followed by 4 min at 50 C) and Arg was
double coupled for 30 min (25 min at RT followed by 5 min
of 75 C). After completed synthesis, resins were washed
(3 9 7 ml, DMF; 4 9 10 ml DCM) and dried under N2.
Cleavage from Resin
Following synthesis, a sample of the resin (50 mg) was taken
out and cleaved with TFA/TIPS/water (95.5:0.25:0.25, 2–3 h,
RT). The cleaved peptide was filtered from resin, dried down to
0.5 ml with N2 and precipitated by the addition of cold
diethylether. The precipitate was collected by centrifugation,
redissolved in 50 % AcN/0.05 %TFA and freeze dried.
Table 1 Synthetic conditions used during peptide elongation
Step Reagents Target temperaturea and duration
Deprotection of resin 20 % piperidine, 7 ml RT, 20 min 9 1
Coupling of Dbz Dbz (1 eqiv.), HBTU (2 eqiv.) DIPEA (3 eqiv.) RT, 30 min 9 2
Deprotection of Dbz 20 % piperidine, 7 ml RT, 20 min 9 2
Initial deprotection of aa 20 % piperidine, 7 ml 70 C, 1 min
Deprotection of aa 20 % piperidine, 7 ml 70 C, 3 min
Coupling of first aa
Gly aa (2 eqiv.), HBTU (2 eqiv.), DIPEA (3 eqiv.) RT, 30 min
Ser aa (4 eqiv.), HBTU (4 eqiv.), DIPEA (6 eqiv.) RT, 30 min (9 2)
Ile/Arg aa (6 eqiv.), HATU (6 eqiv.), DIPEA (9 eqiv.) RT, 1 h 9 2
Coupling of other aa
aa other than Cys or Arg aa (5 eqiv.), HBTU (5 eqiv.), DIPEA (10 eqiv.) 70 C, 5 min
Cys aa (5 eqiv.), HBTU (5 eqiv.), DIPEA (10 eqiv.) RT, 2 min and 50 C, 5 min
Arg aa (5 eqiv.), HBTU (5 eqiv.), DIPEA (10 eqiv.) RT, 25 min and 70 C, 5 min
aa amino acid
a RT indicates coupling at room temperature; dT = 5 min under microwave heating
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Conversion of Dbz-Peptides into Nbz-Peptides
The resin bound peptide containing the Dbz linker was
acylated using 4-nitrophenylchloroformate in DCM
(16 equiv., 0.05 M, 55 min, RT). The resin was washed
well with DCM and activated with 0.5 M DIPEA in DMF
(195 equiv., 0.5 M, 20 min, RT). Resin was washed with
DMF followed by DCM and dried under N2. The peptide-
Nbz was cleaved from the resin using TFA/TIPS/water
(95.5:0.25:0.25, 2–3 h). The precipitated peptide-Nbz was
redissolved in 50 %AcN/0.05 %TFA in water and freeze
dried.
Cyclization/Ligation
A ‘one pot’ buffer for peptide cyclization/ligation was
prepared using 200 mM MPAA, 20 mM TCEP and 6 M
guanidine in a 200 mM phosphate buffer. The pH was
adjusted to be between pH 7.0–7.2. Kalata-Nbz (1 mM)
and SFTI-1 (2 mM) were incubated in the ‘one pot’ buffer
for 24 h. For the ligation of the two defensin fragments,
fragment 1-Nbz (2 mM) and fragment 2 (2.5 mM) were
incubated together in the ‘one pot’ buffer for 24 h. After
24 h the ‘one pot’ buffer containing the cyclized products
was desalted through a Sephadex PD 10 column. The
column was equilibrated with 20 ml of 30 %AcN in water.
The sample of cyclized peptide was dissolved and applied
in 2 ml 30 %AcN solution and eluted with 30 %AcN in
water (3 ml 9 3 fractions). The fractions having the expected
mass for the cyclic/ligated peptides were identified by MS
and freeze dried.
Oxidative Folding
Before oxidative folding, the cyclized kalata B1 was com-
pletely reduced using 10 mM DTT in 0.1 M NH4HCO3
buffer (pH 8.5) for 1 h, purified by RP-HPLC and freeze
dried. Reduced, cyclized kalata B1 was then oxidized in a
folding buffer of 0.1 M NH4HCO4 (pH 8.5) and isopropanol
(50:50 v/v) containing 2 mM reduced glutathione and
0.4 mM oxidized glutathione for 24 h. After 24 h the reaction
mixture was quenched with 0.4 %TFA and purified by RP-
HPLC. SFTI-1 oxidized in the ‘one pot’ buffer for peptide
cyclization/folding.
Results
Synthesis of the Cyclic Cystine Knotted kalata B1
The synthesis of the cyclotide kalata B1 was initiated on the
Tentagel Rink amide resin with a C-terminal Di-Fmoc-3,
4-diaminobenzoic acid (Di-Fmoc-Dbz) linker and an
N-terminal Boc-Cys. Coupling the Di-Fmoc-Dbz linker to
the resin and removal of its Fmoc protecting groups were
carried out manually (outside the synthesizer) at RT. The
choice of the Di-Fmoc-Dbz linker is slightly different from
the Fmoc-3,4-diaminobenzoic acid (Fmoc-Dbz) linker that
was originally reported (Blanco-Canosa and Dawson
2008). The Fmoc-Dbz linker has only one of the two amino
groups protected by Fmoc whereas the linker in the current
study has both amino groups at positions 3 and 4 protected.
Complete coupling of the Di-Fmoc-Dbz occured at only 2
equiv. relative to the resin in contrast to 8 equiv. of Fmoc-
Dbz as reported earlier (Blanco-Canosa and Dawson 2008).
It appears likely that any potential oligomerization of the
Dbz is avoided during coupling as both amino groups are
protected, leading to more efficient coupling.
A complete summary of the synthesis conditions is given
in Table 1. The Gly next to Cys (in loop 3) was selected as the
initiation point for synthesis (highlighted by the arrow in
Fig. 2) to prevent any possibility of epimerization and to
facilitate fast reaction. In all there are five other possible
synthesis initiation points next to the other Cys residues. In
the method introduced by Blanco-Canosa and Dawson
(2008) for the production of peptide thioesters, peptide chain
extension ideally occurs only at one of the two unprotected
amines of the Dbz-linker (either the amine in 3 or 4 position),
whereas the other amine gets inactivated following initial
acylation due to electronic and steric effects. However, one
problem that have been observed for Gly-rich sequences and
long, difficult to synthesize, peptides is the accumulation of
acylated or branched products arising from the second, free,
amine of Dbz (Mahto et al. 2011). To prevent branching, we
coupled the first Gly at 1 equiv. relative to the resin as a single
coupling (30 min, RT). The remaining portion of the peptide
was then elongated in the automated peptide synthesizer by
standard Fmoc SPPS with the assistance of microwave
heating during deprotection and coupling steps. A crude
yield of 63 % was obtained for kalata-Dbz by quantitative
cleavage of a portion of the resin, and integration of the UV
trace at 215 nm gave 76 % purity. Yields and purities are
summarized in Table 2 and masses of synthetic products are
shown in Table 3. Given that this yield was obtained after
single couplings of all amino acids (except Arg) in the
automated synthesizer using the default cycles from the
manufacturer, and without monitoring coupling efficiency,
there could be further room for improving the crude yield of
the peptide. Expected amount of peptide-Dbz was calculated
taking into account the amount of resin cleaved, increase in
resin weight following synthesis, peptide molecular weight
(deprotected and fully protected) and resin substitution value
(see details in Supplementary Information, SI).
As demonstrated in Fig. 3a, one of the isomeric forms of
kalata-Dbz appeared as the main product on RP-HPLC
analysis with the other isomeric form eluting very close to
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Fig. 2 Sequences and schematic representation of the structures of
peptides synthesized in the study. a kalata B1, b SFTI-1 and c the 50
amino acid long spruce defensin 1. The synthesis initiation point in
each peptide is highlighted by arrow(s). Dashed connecting lines
indicated the disulfide bonds and the bold connecting lines indicate
the cyclized backbone






















63 76 62 67 16
SFTI-1 81 79 89 88 50
a Peptide recovery is based on quantitative cleavage of peptide from
resin
b Peptide purity is based on HPLC detection trace at 215 nm
Table 3 Expected and Observed peptide masses




Kalata B1 (cyclized and oxidized) 2891.19 (2891.86)
SFTI-DBZ 1666.88 (1665.94)
SFTI-NBZ 1692.88 (1691.08)
SFTI-1 (cyclized and oxidized) 1513.72 (1512.72)
Defensin peptide 1 1970.84 (1969.84)
Defensin peptide 2-DBZ 3840.01 (3839.01)
Defensin peptide 2-NBZ 3866.01 (3865.10)
Defensin peptide (ligated) 5658.71 (5657.84)
Fig. 3 LC–UV–MS analysis of Dbz and Nbz peptides. a kalata
B1-Dbz, b SFTI-1Arg-Dbz c SFTI-1Ile-Dbz d kalata-Nbz e SFTI-1Arg
-Nbz. Chromatograms show the UV trace at 215 nm; mass spectra of the
main peaks (marked by *) are shown to the right
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the main peak as a secondary peak. In addition, a by-
product with a mass increase of 56.24 Da was observed.
That mass increase may stem from a tert-butyl (tBu) pro-
tecting group (56.11 Da) or an extra Gly residue
(57.05 Da). To rule out that the by-product was not due
to the coupling of Gly on the free amino group on Dbz
(i.e. from branching), MS–MS was done on the ion with the
adduct and of the ‘‘native’’ ion. As shown in SI (Fig. 1), the
analysis clearly showed that the unprotected amine on Dbz
was not acylated, and we conclude that the extra mass was
the result of a tBu-protecting group at a Cys or Thr in the
sequence. Although we repeated our cleavage procedure by
increasing the thiol scavenger (TFA/TIPS/DODT/water,
92.5.5/2.5/2.5/2.5), the peak with the extra mass of 56.24
was still observed as a minor peak.
Following synthesis, the peptide C-terminus was acti-
vated through acylation with p-nitrophenylchloroformate.
Addition of base resulted in the resin-bound peptide
benzimidazolinone (kalata B1-Nbz). After cleavage and
deprotection, kalata B1-Nbz was obtained in 62 % yield
and the purity was 67 % according to HPLC. No amino-
anilide products were observed in the HPLC analysis,
indicating that complete conversion of the benzimidazoli-
none has occurred. The crude peptide-Nbz was then incu-
bated in the ‘one pot’ buffer for thioesterification and
cyclization in situ. After 24 h, cyclized kalata B1 was
purified using SEC with 80 % recovery.
In our early attempt to isolate cyclized kalata B1 by
HPLC from the ‘one pot’ buffer, we observed that cyclized
kalata B1 coeluted with thiols. Although extraction with
diethylether enabled separation of the peptide from thiols, a
significant amount of peptide (*50 %) could not be
recovered through RP-HPLC. Cyclized kalata B1 collected
by SEC contained oxidized Cys, but analytical RP-HPLC
indicated several peaks with retention times earlier than the
native kalata B1, indicative of misfolded kalata B1 (data
not shown). Thus, cyclized kalata B1 was completely
reduced and refolded in a buffer optimized for correct
folding (Daly et al. 2003). Co-injection of 0.1 ll each of
kalata B1 refolded (0.2 mg/ml) and native kalata B1
(0.2 mg/ml) confirmed the native conformation of syn-
thetic kalata B1 (Fig. 4a). From 17.4 mg of peptide-Nbz,
4.2 mg of final pure kalata B1 was obtained. This corre-
sponds to a total yield of 16 %, as calculated from the resin
substitution value.
Synthesis of the Cyclic SFTI-1
Coupling the Di-Fmoc-Dbz linker to the resin was carried
out as previously described in the synthesis of kalata B1.
Two SFTI-1 variants were made; initiated at Arg or at Ile
as outlined in Fig. 2. In each case, the synthesis ended with
an N-terminal Boc-protected Cys-residue. The coupling of
the first amino acid in SFTI-1 variants (SFTI-1Arg and
SFTI-1Ile) gave incomplete coupling when HBTU was used
as the coupling agent: despite increasing the amino acid
and coupling agent equivalents or increasing the coupling
incubation time as (see SFTI-1 syntheses a-d as described
Fig. 4 Analyses and structures
of cyclic end products.
Chromatograms show the co-
injection of synthetic and native
peptides on LC–MS; the mass
spectra of the peaks, and the
structures of a kalata B1 and
b SFTI-1
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in SI). One challenge during peptide synthesis is d-lactam
formation when coupling Arg (Cezari and Juliano 1996).
The formation of d-lactam occurs when the internal nitro-
gen of the guanidine attacks the activated ester, irreversibly
forming the lactam ring. This reaction is competitive with
peptide-bond formation, and greatly reduces the coupling
efficiency of Arg. It is possible that lactam formation is
favored over the coupling of Arg to Dbz when HBTU is
used as a coupling agent. Ile was also difficult to couple to
the Dbz linker using HBTU. It is well established that
b-branched amino acids are prone to form b sheets, often
lead to aggregation during peptide strand elongation
resulting in poor coupling efficiency (Garcia-Ramos et al.
2009). Thus, it appears that the structural features of the
amino acid that is coupled to the Dbz linker could play an
important role in the coupling efficiency. In contrast, the
use of HATU as the coupling agent gave complete cou-
pling of the first amino acids (Arg and Ile) to the Dbz
linker, at 6 equiv. relative to the resin. The full sequence
was then assembled using microwave assisted Fmoc SPPS
on the Liberty1 synthesizer.
One of the most frequently encountered side reactions
affecting Asp in Fmoc SPPS is aspartimide formation,
resulting from a ring closure between the N of the a-carboxy
amide bond and the b-carboxy side chain of the Asp with the
loss of ester protecting group (Tam et al. 1988). The
sequence Asp-Gly is prone to aspartimide formation, which
in turn may undergo base catalysed epimerization to give
a- and b-piperidide products in the presence of piperidine.
SFTI-1 contains the problematic Asp-Gly sequence. In par-
ticular, when the synthesis of SFTI-1 is initiated at Arg, the
Asp-Gly sequence is encountered early in the synthesis
we anticipated that aspartimide formation is likely to
occur due to repeated exposure to piperidine during
synthesis. Thus, the Asp-Gly sequence was introduced
in the form of Fmoc-Asp(OtBu)-(DMB)Gly-OH, with
protecting groups on the N of a-carboxy amide and
b-carboxy side chain, to circumvent the problem in the
final syntheses. Analysis of crude SFTI-Dbz peptides by
RP-HPLC revealed a prominent peak with the corre-
sponding mass for SFTI-Dbz.
Similar to kalata-Dbz synthesis, a by-product with an
extra mass of 56.24 Da was also found for SFTI-1-Dbz, as
indicated in Fig. 3. However, in the case of SFTI, it is clear
from the synthesis in which Asp-Gly was introduced as a
dipeptide, that the adduct can not originate from branching
at the second, free amine, of Dbz. (In that case, the adduct
would have the mass of the dipeptide, not Gly alone).
MS–MS analysis confirmed that there was no branching;
again, a tBu group is the likely culprit for the by-product.
The yield of the crude peptide-Dbz was 81 % for
SFTI-1Arg-Dbz and 77 % for SFTI-1Ile-Dbz. HPLC inte-
gration peaks gave a purity of 79 and 80 %, respectively.
Acylation, activation and cleavage of the acyl urea peptide
were carried out for SFTI-1Arg-Dbz. SFTI-1Arg-Nbz was
obtained in 89 % yield and the purity was 88 %. Yields and
purities are summarized in Table 2 and masses of synthetic
products are shown in Table 3.
After incubation of the crude N-acylurea peptide in
the ‘one pot’ buffer for 24 h, cyclized SFTI-1 was
purified by SEC with 80 % recovery. MS analysis
demonstrated that cysteines were oxidized. Because
SFTI-1 contains only one disulfide bond, it seemed likely
that SFTI-1 attained its native conformation in the ‘one
pot’ buffer. LC–MS analysis confirmed that that was the
case: as shown in Fig. 4, co-injection of equal amounts
of synthetic SFTI-1 and native SFTI-1 co-elutes as a
single peak. On a preparative scale, synthetic SFTI-1
collected from SEC was purified by RP-HPLC as a final
step. From 18.6 mg of peptide-Nbz, 10 mg of pure SFTI-
1 was obtained. This corresponds to a total yield of
50 % of the final product (calculated from the resin
substitution value).
Synthesis of a Plant Defensin by Ligation of Fragments
Encouraged by the successful synthesis of kalata B1 and
SFTI-1, we then decided to apply the same principles
of N-acylurea mediated NCL in the synthesis of a 50-residue
long plant defensin, spruce defensin (SPI1) (Sharma and
Lonneborg 1996; Elfstrand et al. 2001). The defensin was
made in two segments, a 33 residue long N-terminal
peptide containing a C-terminal Dbz linker (Fragment 1)
and the 17 residue C-terminal peptide (Fragment 2). In
Fragment 1, the Di-Fmoc-Dbz group was coupled to a
Clear amide resin and the synthesis was initiated at a Ser
residue, and a Boc-Arg was introduced as the N-terminal
residue. The peptide was elongated by Fmoc SPPS under
microwave heating. Fragment 2 was entirely synthesized
in the microwave synthesizer using a Pro preloaded
resin. During the syntheses, small samples of the resins
were cleaved to confirm synthesis accuracy. Fragment
2 (crude yield of 90 %) was subsequently purified by
RP-HPLC.
Fragment 1-Nbz was generated by the now established
procedures for acylation, activation and cleavage. The two
fragments were then incubated together in the ‘one pot’
buffer for 24 h using a slightly higher concentration of
fragment 2 (2.5 mM for fragment 2 and 2 mM for fragment
1-Nbz). As indicated in Fig. 5, the ligation proceeded
efficiently, and the only side product arose from trace
hydrolysis. The ligated peptide was then collected by SEC
and analysed by LC–MS; the ligated peptide appeared as a
broad peak, presumably due to its larger size (5.6 kDa) and
unfolded conformation.
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Discussion
In the current study we have used N-acylurea mediated
native chemical ligation to generate two model cyclic
peptides and a 50 residue long, linear peptide. The method
relies on the synthesis of a peptide with a C-terminal Dbz
linker and a N-terminal Cys, given the peptide is intended
to be head-to-tail cyclized (kalata B1 and SFTI-1). Alter-
natively, a peptide synthesized with a C-terminal Dbz
linker can be linked to a second peptide containing an
N-terminal Cys, to yield one larger molecule (as in the case
of the defensin). Following synthesis, the Dbz linker is
activated to yield an N-acylurea moiety that acts as poor
nucleophile to efficiently form a thioester at the C-terminal.
In the presence of the N-terminal Cys, the thioester peptide
then participates in NCL to form a native amide bond
leading to either peptide cyclization or ligation.
There are several differences in our synthesis protocol
from the one originally reported by Blanco-Canosa and
Dawson (2008). The type of the Dbz linker used in the
current study has both of its amino groups protected by
Fmoc groups which is advantageous in terms of improving
coupling efficiency as self-dimerization of the linker is
prevented. In addition, we demonstrate that the strategy is
compatible with microwave irradiation for deprotection
and coupling to accelerate the speed of synthesis. Fur-
thermore, we show that Arg, Ile and Ser can be used as
starting points for syntheses; but it appears that the
structural features of the amino acids play an important role
in the coupling efficiency and requires case-specific opti-
mization. Specifically, we found that Arg and Ile require
HATU as a coupling agent, whereas Gly should be coupled
at low equivalences to prevent possible branching of the
second amino group on Dbz. Furthermore, due to the
hydrophobicity of the peptides we have synthesized, their
co-elution with thiols when separated by RP-HPLC has
been problematic. Thus, in place of RP-HPLC, we have
successfully used SEC to desalt the cyclized peptides.
SFTI-1 could be obtained in high total yields compared
to kalata B1 (yields are summarized in Table 2). Because
SFTI-1 is only 14 residues in length and also has only a
single disulfide bond, its synthesis and folding are less
complex than kalata B1. Following incubating SFTI-1-Nbz
in the ‘one pot’ buffer, native SFTI-1 could be easily iso-
lated by SEC and a single step of RP-HPLC. Kalata B1
synthesis is comparatively more laborious and results in
lower yields than SFTI-1 because twice as many coupling
cycles are needed to assemble the 29-residue peptide.
Furthermore, two rounds of HPLC purification were
required for kalata B1, first to isolate the fully reduced
peptide and then to isolate the final native peptide fol-
lowing oxidative folding. However, it should be empha-
sized that no re-couplings (except for Arg) or optimizations
were made for the automated peptide synthesis and the
efficiency of each amino acid coupling was not monitored
by the ninhydrin test. Most likely, there is room for further
improvement of the current synthetic yields.
Currently, there are several methods for the chemical
synthesis of natural and engineered cyclotides, as outlined
in Fig. 6. Boc SPPS based methods were the first to be
developed for cyclotide synthesis and is still the dominat-
ing method. Boc SPPS is often referred to as the most
robust method of cyclotide synthesis, simply because the
linear cyclotide precursors can be conveniently generated
on resin as crude thioester peptides. However, it should be
noted that at least two rounds of purification are required,
first to isolate the desired thioester peptides and then the
cyclized and natively folded cyclotide, with each purifi-
cation step often leading to some amount of unrecoverable
peptide. The microwave assisted Boc SPPS strategy is
reported to give[60 % yield of crude thioester peptide and
20 % yield of pure kalata B1 from thioester peptide.
The need to develop an Fmoc-based strategy without
having to use HF in the final cleavage of peptide from resin
and also with the opportunity to conveniently automate,
drove the search of alternative denovo cyclotide synthesis
methods. Thongyoo et al. successfully synthesized MCoTI-
II by Fmoc synthesis based on a sulfonamide (‘safety
catch’) linker, by activating the thioester precursors
required for NCL following peptide elongation (Thongyoo
et al. 2006). However, the resulting thioester peptide was
Fig. 5 Analysis of truncated counterpart defensin peptides (fragment
1-Dbz and fragment 2) and the ligated spruce defensin peptide.
a Ligated spruce defensin peptide is indicated by * with the
corresponding MS trace. Hydrolyzed Nbz peptide is indicated by an
arrow. b Defensin peptide 1-Dbz, and c defensin peptide 2
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isolated only in 15 % yield and the yield of native peptide
is not reported. We have previously described a
Fmoc SPPS protocol for cyclotide synthesis in which thi-
oester peptide needed for NCL is generated in solution by
reacting a protected peptide with thiols (Fig. 6b) (Leta
Aboye et al. 2008; Park et al. 2010). This strategy gives
good total yields for cyclotides, *22 %kalata B1 and
*11 %MCoTI-I yields (yield calculated from the resins).
One of the advantages of that strategy is that the crude
thioester peptide can be directly converted into a natively
folded, cyclized peptide in a ‘one pot’ buffer without an
intermittent HPLC purification step. However, the need to
make protected peptide has one drawback: the thioesteri-
fication step is extremely sensitive to any residual acid
remaining from the mild acid cleavage, thus efficient
vacuum evaporation (\2 mbar) of the protected peptide
and at least two rounds of lyophilization are necessary to
obtain protected peptide free of residual acid.
In comparison, the current protocol does not require a
protected peptide to be cleaved off from the resin. The
N-acylurea peptides can be directly generated and cleaved
off from the resin followed by in situ thioesterification/
cyclization in a ‘one pot’ buffer. Thus, high yield of cyclic/
ligated peptide can be generated with accelerated speed. In
case of SFTI-1, correct folding also takes place in the ‘one
pot’ buffer, and the native peptide can be isolated in high
yields. In comparison, kalata B1 was completely reduced
and refolded to reach the native disulfide connectivity. The
extra purification required contributes to the lower total
yield of that peptide, but it should be noted that folding
conditions have not yet been optimized: with the increasing
knowledge of cyclotide oxidative folding (Aboye et al.
2011) it is likely that the extra purification step can be
omitted in the future.
To date SFTI-1 has been chemically synthesized by
different approaches. The most robust approach is via Boc
SPPS in which the peptide is synthesized with C-terminal
thioester linker and N-terminal Cys to facilitate cyclization
by NCL (Daly et al. 2006). In addition, linear SFTI-1
precursors have been synthesized by Fmoc SPPS followed
by head-to-tail cyclization to obtain the cyclic backbone
with the assistance of coupling agents such as PyBop
(Zablotna et al. 2002; Swedberg et al. 2011). In that case,
an amino acid side chain protected peptide precursor is
usually required to ensure that amide bond formation
occurs only between an activated C-terminal carboxylate
and an N-terminal Cys. Thus, two cleavage steps are nee-
ded: ‘mild’ cleavage of the protected peptide prior to
cyclization and subsequently a ‘strong’ deprotection. This
may influence the yield of final peptide. In comparison,
N-acyl peptides can be readily generated on resin and
cleaved off from the resin by strong cleavage. Peptide can
be then efficiently cyclized in a one pot buffer leading to
high peptide yields.
The general applicability of the synthesis protocol was
exemplified by the synthesis of a 50-residue long plant
Fig. 6 Different cyclotide
synthesis strategies. a Boc SPPS
strategy, b Fmoc SPPS strategy
(based on thioesterification of
protected peptide) and c the
Fmoc SPPS strategy used
in the current work (based
on N-acylurea peptide
intermediates)
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defensin. In principle, we have shown that a large, difficult
to synthesize peptide can be ligated via two shorter frag-
ments using the N-acylurea approach. Although we cur-
rently only have demonstrated the utility of this ligation
approach in Cys containing peptides, other potential liga-
tion sites such as Ala or Val broadens the applicability of
this approach in the synthesis of peptides that do not
contain Cys. For instance, desulfurization allows penicil-
lamine to be converted into Val (Haase et al. 2008) and Cys
into Ala (Wan and Danishefsky 2007). Hence, the current
approach in combination with desulfurization can poten-
tially be used to ligate peptides that lack Cys, given that
they fulfill the requirement of an Ala or Val at the ligation
site.
A user-friendly and time-efficient method of synthesis is
a primary requirement to exploit the drug development
aspects of cyclic peptides or to dissect their structure–
activity relationships. As such the method presented in this
study is timely, as many laboratories are becoming more
inclined to use Fmoc SPPS rather than Boc SPPS and
because of the increasing popularity of microwave assisted
for peptide synthesis. In addition, the interest of using
cyclic peptides as stable drug scaffolds is growing, and
includes studies of naturally occurring cyclic peptides but
also to the re-engineering of linear peptides by cyclization
of the peptide backbone. In addition to cyclotides and
SFTI-1, which both are currently scrutinized as scaffolds
for drug discovery, current examples include the develop-
ment of HIV inhibitors from retrocyclins, synthetic
cyclic peptides derived from the primate h defensin genes
(Penberthy et al. 2011), and the cyclization of the cono-
toxin Vc1.1, which is now undergoing preclinical devel-
opment for the treatment of neuropathic pain (Carstens
et al. 2011). We anticipate that the protocol described in
the current paper may advance the use of cyclic peptides
for drug development, but also for a fragment based syn-
thesis approach of larger proteins, exploiting the power of
microwave assisted peptide synthesis.
Conclusion
With the rising interest in cyclization as a tool to improve
stability of peptides, the chemical synthesis of proteins, and
the increasing use of microwave assisted peptide synthesis,
there is a need for the continued development of new
methods. The current work expands the applications of the
C-terminal N-acylurea approach for NCL reported by
(Blanco-Canosa and Dawson 2008). By including high-
yielding and rapid microwave Fmoc SPPS in the protocol,
the door is wide open for the efficient ligation of cyclic
peptides or larger proteins by making ends meet.
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